Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart A Cook

Showing results (161-170 of 213) with videos related to

Pageof 22
Sort By:
Science Translational Medicine|September 27, 2019
Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosisBenjamin Ng, Jinrui Dong, Giuseppe D'Agostino, et al.
JACC. Heart Failure|November 30, 2023
Sex Differences in the Clinical Presentation and Natural History of Dilated CardiomyopathyRuth Owen, Rachel Buchan, Michael Frenneaux, et al.
JAMA|March 7, 2013
Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathyAnkur Gulati, Andrew Jabbour, Tevfik F Ismail, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 13, 2018
A gene-centric strategy for identifying disease-causing rare variants in dilated cardiomyopathyClaire Horvat, Renee Johnson, Lien Lam, et al.
Science Translational Medicine|June 10, 2021
Redefining IL11 as a regeneration-limiting hepatotoxin and therapeutic target in acetaminophen-induced liver injuryAnissa A Widjaja, Jinrui Dong, Eleonora Adami, et al.
American Journal of Human Genetics|August 31, 2023
The penetrance of rare variants in cardiomyopathy-associated genes: A cross-sectional approach to estimating penetrance for secondary findingsKathryn A McGurk, Xiaolei Zhang, Pantazis Theotokis, et al.
Gastroenterology|May 13, 2019
Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic SteatohepatitisAnissa A Widjaja, Brijesh K Singh, Eleonora Adami, et al.
Nature Genetics|April 30, 2008
Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular massEnrico Petretto, Rizwan Sarwar, Ian Grieve, et al.
American Journal of Human Genetics|June 18, 2013
Fine mapping of the 1p36 deletion syndrome identifies mutation of PRDM16 as a cause of cardiomyopathyAnne-Karin Arndt, Sebastian Schafer, Jorg-Detlef Drenckhahn, et al.
Circulation|March 30, 2017
Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic DysfunctionBrian P Halliday, Ankur Gulati, Aamir Ali, et al.
Pageof 22

Showing results (161-170 of 213) with videos related to

Sort By:
Pageof 22
Science Translational Medicine|September 27, 2019
Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosisBenjamin Ng, Jinrui Dong, Giuseppe D'Agostino, et al.
JACC. Heart Failure|November 30, 2023
Sex Differences in the Clinical Presentation and Natural History of Dilated CardiomyopathyRuth Owen, Rachel Buchan, Michael Frenneaux, et al.
JAMA|March 7, 2013
Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathyAnkur Gulati, Andrew Jabbour, Tevfik F Ismail, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 13, 2018
A gene-centric strategy for identifying disease-causing rare variants in dilated cardiomyopathyClaire Horvat, Renee Johnson, Lien Lam, et al.
Science Translational Medicine|June 10, 2021
Redefining IL11 as a regeneration-limiting hepatotoxin and therapeutic target in acetaminophen-induced liver injuryAnissa A Widjaja, Jinrui Dong, Eleonora Adami, et al.
American Journal of Human Genetics|August 31, 2023
The penetrance of rare variants in cardiomyopathy-associated genes: A cross-sectional approach to estimating penetrance for secondary findingsKathryn A McGurk, Xiaolei Zhang, Pantazis Theotokis, et al.
Gastroenterology|May 13, 2019
Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic SteatohepatitisAnissa A Widjaja, Brijesh K Singh, Eleonora Adami, et al.
Nature Genetics|April 30, 2008
Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular massEnrico Petretto, Rizwan Sarwar, Ian Grieve, et al.
American Journal of Human Genetics|June 18, 2013
Fine mapping of the 1p36 deletion syndrome identifies mutation of PRDM16 as a cause of cardiomyopathyAnne-Karin Arndt, Sebastian Schafer, Jorg-Detlef Drenckhahn, et al.
Circulation|March 30, 2017
Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic DysfunctionBrian P Halliday, Ankur Gulati, Aamir Ali, et al.
Pageof 22